本文报告16例脾切除治疗再生障碍性贫血的远期疗效。随访时间2～23年,平均13年。结果有效率为87.5%,基本治愈率37.5%,缓解率31.2%。与内科治疗基本情况相同的20例再障相比,基本治愈及有效率均明显增高,说明脾切除术冶疗本病以优于内科疗法。对脾切除的指征及机理作了简要的讨论。 This article reports 16 cases of splenectomy for the treatment of aplastic anemia long-term efficacy. Follow-up time of 2 to 23 years, an average of 13 years. Results The effective rate was 87.5%, the basic cure rate was 37.5% and the remission rate was 31.2%. Compared with the same basic medical treatment of 20 cases of aplastic anemia, the basic cure and effective rate were significantly increased, indicating that the splenectomy cure the disease better than medical therapy. The indications and mechanism of splenectomy made a brief discussion.